![](/img/cover-not-exists.png)
Thirty-three per cent of relapsing prostate cancer patients show a positive objective response to flutamide in combination with castration (surgical or medical)
F. Labrie, A. Dupont, M. Giguère, J.-P. Borsanyi, Y. LacourcièreVolume:
25
Year:
1986
Language:
english
DOI:
10.1016/0022-4731(86)90821-6
File:
PDF, 153 KB
english, 1986